About Veracyte, Inc

Veracyte is a leading genomic diagnostics company that is fundamentally improving patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable. Our products uniquely combine genomic technology, clinical science and machine learning to provide answers that give physicians and patients a clear path forward without risky, costly surgery that is often unnecessary. Since our founding in 2008, we have commercialized three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis, respectively.

We estimate that to date, we have helped tens of thousands of patients avoid unnecessary surgery and have removed hundreds of millions of dollars in costs from the healthcare system.

+ more
Where to find Veracyte, Inc